These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
611 related articles for article (PubMed ID: 32319118)
1. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover. Soresina A; Moratto D; Chiarini M; Paolillo C; Baresi G; Focà E; Bezzi M; Baronio B; Giacomelli M; Badolato R Pediatr Allergy Immunol; 2020 Jul; 31(5):565-569. PubMed ID: 32319118 [TBL] [Abstract][Full Text] [Related]
2. The Clinical Course of COVID-19 Pneumonia in a 19-Year-Old Man on Intravenous Immunoglobulin Replacement Therapy for X-Linked Agammaglobulinemia. Almontasheri A; Al-Husayni F; Alsuraihi AK; Binyahib H; Albanna AS Am J Case Rep; 2021 Feb; 22():e929447. PubMed ID: 33612712 [TBL] [Abstract][Full Text] [Related]
3. Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma. Jin H; Reed JC; Liu STH; Ho HE; Lopes JP; Ramsey NB; Waqar O; Rahman F; Aberg JA; Bouvier NM; Cunningham-Rundles C; J Allergy Clin Immunol Pract; 2020; 8(10):3594-3596.e3. PubMed ID: 32947026 [No Abstract] [Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
5. Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19. Luetkens T; Metcalf R; Planelles V; Zheng Y; Larragoite ET; Spivak ES; Spivak AM; Steinbach M; Blaylock RC; Avila SV; Hankey KG; Martins TB; Slev PR; Mannuel HD; Sajadi M; Rapoport AP; Atanackovic D Blood Adv; 2020 Oct; 4(19):4864-4868. PubMed ID: 33031540 [TBL] [Abstract][Full Text] [Related]
6. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report. d'Ettorre G; Recchia G; Ridolfi M; Siccardi G; Pinacchio C; Innocenti GP; Santinelli L; Frasca F; Bitossi C; Ceccarelli G; Borrazzo C; Antonelli G; Scagnolari C; Mastroianni CM Medicine (Baltimore); 2020 Sep; 99(36):e21803. PubMed ID: 32899009 [TBL] [Abstract][Full Text] [Related]
7. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma. Mira E; Yarce OA; Ortega C; Fernández S; Pascual NM; Gómez C; Alvarez MA; Molina IJ; Lama R; Santamaria M J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2793-2795. PubMed ID: 32652231 [No Abstract] [Full Text] [Related]
8. Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study. D'Andrea S; Berardicurti O; Berardicurti A; Felzani G; Francavilla F; Francavilla S; Giacomelli R; Barbonetti A Spinal Cord Ser Cases; 2020 Aug; 6(1):69. PubMed ID: 32753638 [TBL] [Abstract][Full Text] [Related]
9. Case report: Evolution of pulmonary manifestations and virological markers in critical COVID-19 infection in Bruton's agammaglobulinemia. Rise N; Touborg T; Lundsted DH; Dalager-Pedersen M; Mogensen TH Front Immunol; 2022; 13():1057065. PubMed ID: 36505407 [TBL] [Abstract][Full Text] [Related]
10. X-Linked Agammaglobulinemia and COVID-19: Two Case Reports and Review of Literature. Devassikutty FM; Jain A; Edavazhippurath A; Joseph MC; Peedikayil MMT; Scaria V; Sandhya P; Govindaraj GM Pediatr Allergy Immunol Pulmonol; 2021 Sep; 34(3):115-118. PubMed ID: 34495748 [No Abstract] [Full Text] [Related]
11. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial. Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849 [TBL] [Abstract][Full Text] [Related]
12. Guillain-Barré syndrome associated with SARS-CoV-2 infection. Comments after 16 published cases. Guijarro-Castro C; Rosón-González M; Abreu A; García-Arratibel A; Ochoa-Mulas M Neurologia (Engl Ed); 2020; 35(6):412-415. PubMed ID: 32565036 [No Abstract] [Full Text] [Related]
14. A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward. Wang B; Van Oekelen O; Mouhieddine TH; Del Valle DM; Richter J; Cho HJ; Richard S; Chari A; Gnjatic S; Merad M; Jagannath S; Parekh S; Madduri D J Hematol Oncol; 2020 Jul; 13(1):94. PubMed ID: 32664919 [TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes? Mégarbane B; Scherrmann JM J Clin Pharmacol; 2020 Jul; 60(7):808-814. PubMed ID: 32434282 [No Abstract] [Full Text] [Related]
16. COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients. Colombi D; Bodini FC; Morelli N; Silva M; Milanese G; Cavanna L; Michieletti E J Infect Chemother; 2021 Jan; 27(1):99-102. PubMed ID: 33023821 [TBL] [Abstract][Full Text] [Related]
17. A child infected with severe acute respiratory syndrome coronavirus 2 presenting with diarrhea without fever and cough: A case report. Liu Q; Zhang Y; Long Y Medicine (Baltimore); 2020 Aug; 99(33):e21427. PubMed ID: 32871990 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients. Zen M; Fuzzi E; Astorri D; Saccon F; Padoan R; Ienna L; Cozzi G; Depascale R; Zanatta E; Gasparotto M; Benvenuti F; Bindoli S; Gatto M; Felicetti M; Ortolan A; Campaniello D; Larosa M; Lorenzin M; Ramonda R; Sfriso P; Schiavon F; Iaccarino L; Doria A J Autoimmun; 2020 Aug; 112():102502. PubMed ID: 32527675 [TBL] [Abstract][Full Text] [Related]
19. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia. Quinti I; Lougaris V; Milito C; Cinetto F; Pecoraro A; Mezzaroma I; Mastroianni CM; Turriziani O; Bondioni MP; Filippini M; Soresina A; Spadaro G; Agostini C; Carsetti R; Plebani A J Allergy Clin Immunol; 2020 Jul; 146(1):211-213.e4. PubMed ID: 32333914 [No Abstract] [Full Text] [Related]
20. New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Assini A; Benedetti L; Di Maio S; Schirinzi E; Del Sette M Neurol Sci; 2020 Jul; 41(7):1657-1658. PubMed ID: 32468450 [No Abstract] [Full Text] [Related] [Next] [New Search]